A detailed history of Brucke Financial, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Brucke Financial, Inc. holds 11,476 shares of AZN stock, worth $1.03 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
11,476
Previous 8,607 33.33%
Holding current value
$1.03 Million
Previous $601 Million 57.22%
% of portfolio
0.55%
Previous 0.42%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$68.72 - $82.11 $197,157 - $235,573
2,869 Added 33.33%
11,476 $946 Million
Q2 2025

Jul 24, 2025

BUY
$64.87 - $75.0 $4,216 - $4,875
65 Added 0.76%
8,607 $601 Million
Q1 2025

May 07, 2025

SELL
$65.37 - $77.96 $17,126 - $20,425
-262 Reduced 2.98%
8,542 $613 Million
Q4 2024

Feb 27, 2025

BUY
$63.2 - $79.58 $556,412 - $700,622
8,804 New
8,804 $623 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $277B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Brucke Financial, Inc. Portfolio

Follow Brucke Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brucke Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brucke Financial, Inc. with notifications on news.